sellWeak cluster of 210b5-1 plan
Snehashish Sarkar sold $25k of ACH
other at ACCENDRA HEALTH INC/VA/. 2,055 shares at an average of $12.26, traded Nov 18, 2024, filed Nov 19, 2024.
Warning score
1Value
$25k
2,055 shares
Holdings after
55,886
-4% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +8RoleOther
- +5Trade size$25k at market
- 0Share of holdings soldSold 3.5% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001062993-24-019366, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | FTax withholding Common Stock10b5-1 | -1,196 | $12.27 | $15k | 57,941 | Nov 19, 2024 |
| Nov 18, 2024 | SOpen-market sale Common Stock10b5-1 | -2,055 | $12.26 | $25k | 55,886 | Nov 19, 2024 |
Related signals
Other insiders at ACCENDRA HEALTH INC/VA/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | ACHbuy ACCENDRA HEALTH INC/VA/ | Coliseum Capital Management, LLC owner | $8.1M 1,537,852 shares | +13% | |
| 45Moderate | ACHbuy ACCENDRA HEALTH INC/VA/ | Coliseum Capital Management, LLC owner | $3.1M 410,000 shares | +4% | |
| 45Moderate | ACHbuy ACCENDRA HEALTH INC/VA/ | Coliseum Capital Management, LLC owner | $4.3M 528,356 shares | +5% | |
| 38Weak | ACHbuy ACCENDRA HEALTH INC/VA/ | Coliseum Capital Management, LLC owner | $27M 2,893,412 shares | +37% | |
| 17Weak | ACCENDRA HEALTH INC/VA/ | Jonathan A Leon EVP, Chief Financial Officer | $62k 5,282 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.